Walmart remains committed to health center expansion
August 19, 2020 – Walmart CEO Doug McMillon said yesterday that the company remains committed to its roll out of Walmart Health brand centers to…
JHC’s Dail-eNews
Abbott releases new research on challenges of caring for cardiovascular patients
August 19, 2020 – New global research released by Abbott (Abbott Park, IL) takes a deep dive into the barriers of cardiovascular patient care and…
Clear link between heart disease and COVID-19; Long-term implications unknown
August 19, 2020 – Severe damage to the lungs is one of COVID-19’s most harrowing effects, making breathing hard or impossible for those who’re severely…
Premier Inc., AstraZeneca work to reduce hospitalizations of patients with hyperkalemia
August 18, 2020 – Premier Inc. (Charlotte, NC) has reached a significant milestone in its partnership with AstraZeneca that is aimed at reducing hospitalizations among…
McKesson named to Diversity Best Practices Inclusion Index
August 18, 2020 – McKesson announced it was named to the Diversity Best Practices (DBP) fourth annual Inclusion Index. McKesson was among the 98 organizations…
Intalere launches exclusive Intalere Knowledge hub
August 18, 2020 – Intalere (St. Louis, MO) launched the Intalere Knowledge Hub – a centralized, on-demand portal where members can access CE sessions and…
GHX experts to share insights at IDN Summit and AHRMM20+ virtual events
August 18, 2020 – Global Healthcare Exchange, LLC (GHX) (Louisville, CO) announced Karen Conway, VP of Healthcare Value; and Lumere Chief Medical Officer John Cherf,…
Intermountain’s SelectHealth names Mike Cotton as president, CEO
August 18, 2020 – Mike Cotton was named president and CEO of SelectHealth, the wholly owned subsidiary health plan of Intermountain Healthcare, and will serve…
Masimo PVi receives FDA clearance as indicator of fluid responsiveness on mechanically ventilated patients
August 17, 2020 – Masimo (Irvine, CA) announced that PVi (pleth variability index) has received FDA clearance as a continuous, noninvasive, dynamic indicator of fluid…
FDA approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)
August 17, 2020 – Roche (Basel, Switzerland) announced that the U.S. Food and Drug Administration (FDA) has approved ENSPRYNG (satralizumab-mwge) as the first and only…